Teledoc rallies after being named a ‘surefire growth stock’

 

• Teladoc Health (NYSE:TDOC) is +1.4% in pre-market trading as Motley Fool author, Danny Vena, names it as among ‘3 Surefire Growth Stocks to Buy Before 2021.’
• Citing the company’s exponential revenue growth, and the recent acquisition of chronic-care specialist Livongo (NASDAQ:LVGO), Vena says Teladoc is best positioned to capitalize on the growing trend towards telehealth and telemedicine, which was accelerated by the COVID-19 pandemic.
• With even a stronger adoption of the platform in the home bastion of U.S., the company saw a two-fold rise in revenue in Q3 2020, notes the author, adding that its international growth, making up only a small fraction of business ‘has only just begun.’
• The acquisition of Livongo Health, which had triple-digit growth before the merger, will ‘cement the company's leadership in virtual care.’ concludes Vena.
• https://seekingalpha.com/news/3646181-teledoc-rallies-in-pre-market-after-being-named-surefire-growth-stock